A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.

Using data from the T2T reference, scientists linked two new genes to changes in brain size and synapse signaling.

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests.

Modulating microbiome composition after allogeneic hematopoietic stem cell transplantation may help oncologists prevent bloodstream infections posttreatment.

Johns Hopkins researchers found that tumor-derived mutations can be detected in blood up to three years before cancer diagnosis, offering the potential for earlier intervention.

Blood tests that promise a head start against cancer are on the rise. The hard part? Showing that finding disease sooner actually saves lives.

Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called "Fragle" that makes tracking cancer easier and faster ...

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson | Dubbed ...

Liquid biopsy tests are growing in use and showing promise in cancer detection, but experts say more trials are needed on the clinical benefit of ctDNA testing.

Visual capturing and profiling of circulating tumor cells from breast cancer patient’s blood via combining fluorescent IMNPs in a magnet-integrated 3D-printed microfluidic chip.